Start Date
April 30, 2010
Primary Completion Date
May 31, 2012
Study Completion Date
June 30, 2012
PRGF
enriched plasma fraction will be then injected to the trial group in sterile conditions under ultrasound control in the ssp gap
NACL
Nack 0.9 5 will be then injected to the control group group in sterile conditions under ultrasound control
Orthopedic Department - Meir Medical Center, Kfar Saba
Lead Sponsor
Meir Medical Center
OTHER